---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005876"
form_type: "8-K"
ticker: "COCP"
cik: "0001412486"
company_name: "Cocrystal Pharma, Inc."
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T07:57:40.099835+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Cocrystal Pharma furnishes corporate presentation with no material new disclosures

## Summary
- Filed an investor presentation on April 23, 2025 under Item 7.01 Regulation FD.
- Presentation content not provided; no specific data on pipeline, finances, or milestones.
- No material operational, financial, or strategic updates disclosed in the filing.

## SEC filing metadata
- accession: 0001641172-25-005876
- form_type: 8-K
- ticker: COCP
- cik: 0001412486
- company_name: Cocrystal Pharma, Inc.
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412486/000164117225005876/0001641172-25-005876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412486/000164117225005876/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005876
- JSON: https://secwatch.observer/filing/0001641172-25-005876.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005876.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.